REG - GenIP PLC - Result of AGM

GenipAnnouncement

26/06/2025 17:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250626:nRSZ6288Oa&default-theme=true

RNS Number : 6288O  GenIP PLC  26 June 2025

 

 

26 June 2025

GenIP Plc

("GenIP" or the "Company")

Result of AGM

 

GenIP Plc (AIM: GNIP), a technology business providing Generative Artificial
Intelligence (GenAI) solutions to help research organisations and corporations
commercialise their innovations, is pleased to announce that at the Company's
Annual General Meeting ("AGM") held earlier today all resolutions were duly
passed.

 

The number of votes cast for and against each of the resolutions proposed, and
the number of votes withheld were as follows:

 

 Resolution                                                                      For         %      Against  %     Votes withheld  Total votes cast
 Ordinary Resolutions
 (1)   Approval of the Annual Report and Accounts                                13,895,578  99.95  6,685    0.05  104,665         13,902,263
 (2)   Re-appoint HW Fisher LLP as auditor of the Company                        13,895,578  99.95  6,685    0.05  104,665         13,902,263
 (3)   Authorise the Directors to determine the auditor's remuneration           13,895,578  99.95  6,685    0.05  104,665         13,902,263
 (4)   Re-elect Lord David Willetts as a director of the Company                 13,767,373  99.03  134,890  0.97  104,665         13,902,263
 (5)   Re-elect Melissa Cruz as a director of the Company                        13,767,373  99.03  134,890  0.97  104,665         13,902,263
 (6)   Re-elect Kevin Fitzpatrick as a director of the Company                   13,895,578  99.95  6,685    0.05  104,665         13,902,263
 (7)   Re-elect Prof. David Gann CBE as a director of the Company                13,767,373  99.03  134,890  0.97  104,665         13,902,263
 (8)   To authorise the Directors to allot shares, up to an aggregate nominal    13,759,681  99.03  134,890  0.97  112,357         13,894,571
 amount of £37,224.61
 Special Resolution
 (9)   To authorise the Directors to disapply pre-emption rights when issuing    13,759,681  99.03  134,890  0.97  112,357         13,894,571
 share, up to an aggregate nominal amount of £37,224.61

 

Notes:

1.     Proxy appointments which gave discretion to the Chairman of the AGM
have been included in the "For" total for the appropriate resolution.

2.     Votes "For" and "Against" any resolution are expressed as a
percentage of votes validly cast for that resolution.

3.     A "Vote withheld" is not a vote in law and is not counted in the
calculation of the percentage of shares voted "For" or "Against".

4.     The full text of the resolutions passed at the AGM can be found in
the Notice of Annual General Meeting which is available on the Company's
website at http://genip.ai/results-presentations/.

 

As at 26 June 2025, there were 17,517,461 ordinary shares in issue.
Shareholders are entitled to one vote per share.

 

Votes withheld are not votes in law and so have not been included in the
calculation of the proportion of votes for and against a resolution.

 

Enquiries:

 

 GenIP Plc                                                                 Via Redchurch Communications

 Melissa Cruz, CEO

 Beaumont Cornish Limited (Nominated Adviser)                              Tel:  +44 (0) 20 7628 3396

 Roland Cornish / Asia Szusciak / Andrew Price

 Novum Securities Limited (Broker)                                         Tel: +44 (0)20 7399 9425

 Jon Belliss                                                               JBelliss@novumsecurities.com

 Redchurch Communications (Financial PR)                                   genip@weareredchurch.com (mailto:genip@weareredchurch.com)

 John Casey

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated
Adviser and is authorised and regulated by the FCA. Beaumont Cornish's
responsibilities as the Company's Nominated Adviser, including a
responsibility to advise and guide the Company on its responsibilities under
the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed
solely to the London Stock Exchange. Beaumont Cornish is not acting for and
will not be responsible to any other persons for providing protections
afforded to customers of Beaumont Cornish nor for advising them in relation to
the proposed arrangements described in this announcement or any matter
referred to in it.

About GenIP
 
GenIP provides generative artificial intelligence (GenAI) analytic services to help companies, research institutions and venture funds assess and commercialise new discoveries. GenIP combines expert human technical review with GenAI algorithms to provide insightful and verified services.
 
GenIP provides two complementary platform-based services:
 
1.   Invention Evaluator: Provides bespoke research reports that assess the market potential of new technological innovations and discoveries using AI-driven proprietary software; and
 
2.   Vortechs: which is an executive recruitment platform that through advanced machine learning algorithms and natural language processing technologies assists in matching technology organisations with experienced executives skilled in technology commercialisation.
 
The Company believes that its integrated GenAI service offerings will help organisations to evaluate and commercialise their technological innovations.
 
Company Strategy
 
GenIP's goal is to be a leading Generative AI analytic services company. To achieve this, the Company has established three strategic pillars:
 
·           Organically grow Invention Evaluator and Vortechs' revenue through institutional and corporate connections as well as increase client pipeline through marketing, advertising and social media spend.
 
·           Expand the Generative AI service offerings within Invention Evaluator and Vortechs' to reach new customers and improve margins.
 
·           Bolt-on acquisitions of additional Generative AI services that are helpful to our clients and have demonstrated initial market traction.
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGPKABBPBKDFAB